-
1
المؤلفون: Elena, Guillen, Niklas, Ekman, Sean, Barry, Martina, Weise, Elena, Wolff-Holz
المساهمون: Institut Català de la Salut, [Guillen E] Departament de Farmacologia, Terapèutica i Toxicologia, Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Farmacologia Clínica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Ekman N] Finnish Medicines Agency Fimea, Helsinki, Finland. [Barry S] Health Products Regulatory Authority, Dublin, Ireland. [Weise M] Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM), Bonn, Germany. [Wolff-Holz E] Paul-Ehrlich-Institut PEI, Langen, Germany, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
مصطلحات موضوعية: Pharmacology, Anticossos monoclonals - Ús terapèutic, Productes biològics, Adalimumab, Antibodies, Monoclonal, Health Care Quality, Access, and Evaluation::Delivery of Health Care [HEALTH CARE], calidad, acceso y evaluación de la atención sanitaria::prestación sanitaria [ATENCIÓN DE SALUD], mezclas complejas::productos biológicos::fármacos biosimilares [COMPUESTOS QUÍMICOS Y DROGAS], Bevacizumab, Assistència sanitària, Humans, Pharmacology (medical), European Union, Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal [CHEMICALS AND DRUGS], Biosimilar Pharmaceuticals, aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales [COMPUESTOS QUÍMICOS Y DROGAS], Complex Mixtures::Biological Products::Biosimilar Pharmaceuticals [CHEMICALS AND DRUGS]
وصف الملف: application/pdf
-
2
المؤلفون: Ingrid Bourges, Pekka Kurki, Panagiota Tsantili, Elena Wolff-Holz, Sean Barry
المساهمون: University of Helsinki, Department of Medicine
المصدر: Drugs, 81:1881-1896
Drugsمصطلحات موضوعية: medicine.medical_specialty, medicine.drug_class, Postmarketing surveillance, Monoclonal antibody, Interchangeability, 03 medical and health sciences, 0302 clinical medicine, Product Surveillance, Postmarketing, Adverse Drug Reaction Reporting Systems, Humans, Immunologic Factors, Medicine, media_common.cataloged_instance, Pharmacology (medical), Original Research Article, European Union, APPRAISAL, European union, Intensive care medicine, Adverse effect, Biosimilar Pharmaceuticals, Drug Approval, media_common, Biosimilars, 030203 arthritis & rheumatology, Drug Substitution, business.industry, Immunogenicity, Antibodies, Monoclonal, Biosimilar, Fusion protein, 3. Good health, Therapeutic Equivalency, 317 Pharmacy, MEDICINES, 030220 oncology & carcinogenesis, Drug and Narcotic Control, business
-
3
المؤلفون: Pekka Kurki, Hye-Na Kang, Niklas Ekman, Ivana Knezevic, Martina Weise, Elena Wolff-Holz
المصدر: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. 36(3)
مصطلحات موضوعية: Pharmacology, Uncertainty, Humans, Pharmacology (medical), General Medicine, World Health Organization, Biosimilar Pharmaceuticals, Drug Packaging, Biotechnology
-
4
المؤلفون: Elena Wolff-Holz, Martina Weise
المصدر: Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 63:1365-1372
مصطلحات موضوعية: Gynecology, 03 medical and health sciences, medicine.medical_specialty, Reference product, 0302 clinical medicine, Political science, Public Health, Environmental and Occupational Health, medicine, 030212 general & internal medicine, 030210 environmental & occupational health
-
5
المصدر: Health Policy and Technology. 9:129-133
مصطلحات موضوعية: Health Policy, Biomedical Engineering, Biosimilar, Engineering ethics, Business
-
6
المؤلفون: Andrea Laslop, Thijs J Giezen, Martina Weise, Elena Wolff-Holz, Luis Pinheiro, Ana Hidalgo-Simon
المصدر: Clinical pharmacology & therapeutics, 110(5):1311-1317
مصطلحات موضوعية: medicine.medical_specialty, Databases, Factual, Drug-Related Side Effects and Adverse Reactions, Risk Assessment, Biological Factors, Pharmacovigilance, Antineoplastic Agents, Immunological, medicine, media_common.cataloged_instance, Adverse Drug Reaction Reporting Systems, Humans, Pharmacology (medical), Drug reaction, European Union, European union, Intensive care medicine, Biosimilar Pharmaceuticals, media_common, Pharmacology, business.industry, Biologika, Biosimilar, medicine.disease, Identification (information), General level, Identifiability, business, Rituximab, Adverse drug reaction
-
7
المساهمون: Pharmacy
المصدر: Clinical Pharmacology and Therapeutics
Clinical Pharmacology & Therapeutics, 105(4), 962-969. Wiley-Blackwellمصطلحات موضوعية: medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, 030226 pharmacology & pharmacy, Article, Pharmacovigilance, 03 medical and health sciences, 0302 clinical medicine, medicine, Adverse Drug Reaction Reporting Systems, Humans, Pharmacology (medical), Drug reaction, Intensive care medicine, Biosimilar Pharmaceuticals, Pharmacology, Biological Products, business.industry, Research, Treatment options, Biosimilar, Articles, medicine.disease, Europe, Clinical Practice, 030220 oncology & carcinogenesis, Identifiability, business, Adverse drug reaction
وصف الملف: application/pdf
-
8
المؤلفون: Elena, Wolff-Holz, Martina, Weise
المصدر: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 63(11)
مصطلحات موضوعية: Germany, Antibodies, Monoclonal, Humans, European Union, Biosimilar Pharmaceuticals
-
9
المؤلفون: Elena Wolff-Holz, Jan Müller-Berghaus, Martina Weise
المصدر: Deutsches Ärzteblatt Online.
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7033f131a041c6c738be0bdcb7f796cf
https://doi.org/10.3238/personko.2020.03.13.04 -
10
المؤلفون: Elena Wolff-Holz, Jan Müller-Berghaus, Martina Weise
المصدر: Deutsches Ärzteblatt Online.
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::1acfc398c455034c1c9aafd3b026f61f
https://doi.org/10.3238/personko.2019.11.15.03
Find this article in full text from Springer Verlag.